Posted on 3 月 25, 20253/25/25
The End of the Blockbuster: Adapting to a New Pharmaceutical Landscape With a New Commercialization Model
Posted on 3 月 21, 20253/21/25
Capital Efficient Commercialization: A New Model for Success
Posted on 3 月 21, 20253/21/25
Boosting Pharma Efficiency: A New Model for Asset Value Retention
Posted on 3 月 19, 20253/19/25
Maximizing Sales with AI: A Strategic Roadmap for Success
Posted on 3 月 12, 20253/12/25
Making Cutting-Edge Cancer Treatments Accessible: Advancing CAR-T Therapy to the Community Practice
Posted on 3 月 2, 20253/2/25
The Path to Maximizing Revenue: How to Simplify Pharmaceutical Commercialization and Find Optimum Success
Posted on 2 月 28, 20252/28/25
Successfully Navigating the Complexity of Market Access Across Europe to Improve Health Equity
Posted on 1 月 8, 20251/8/25
Point-of-Care (POC) Diagnostics: Transformation From Pre- to Post- Pandemic: An Asian Perspective
Posted on 1 月 8, 20251/8/25